What Do AI Agents Do in Healthcare, Finance, and Other Industries?

robots using laptops

Key Takeaways:

  • Agents deliver different types of value depending on the sector. Healthcare’s gains show up mainly as staffing and cost reductions (60-80% fewer manual administrative FTEs), while finance’s gains show up as return on investment (77% ROI on agent deployments) — two related but distinct ways of measuring success.
  • The strongest results come from full production deployments, not early pilots. Both the healthcare and finance data points reflect organizations that had already worked through integration and governance challenges, not the average experience of every adopter.
  • Agents work best on repetitive, rules-based, high-volume tasks. Whether it’s prior authorization in healthcare or fraud detection in finance, the common formula is the agent handling the routine cases and escalating the harder ones to a human.
  • Integration depth and data governance are the real differentiators. Shallow integrations tend to produce shallow results, and inconsistent measurement practices are a major reason why reported outcomes vary so widely between organizations in the same industry.
  • Adoption is reshaping jobs rather than eliminating them outright. Roles across claims processing, compliance, customer service, and supply chain planning are shifting toward oversight of automated systems, making workforce training and change management as important as the technology itself.

AI agents have moved past the pilot stage and into daily operations across nearly every major sector. Unlike a chatbot that answers a single question, an AI agent can carry out an entire multi-step task on its own, reasoning through exceptions and only asking for human input when something genuinely requires it. That shift, from answering questions to completing work, is why 2026 has become the year these systems started showing up in earnings reports, staffing plans, and compliance reviews rather than just innovation slide decks. This article looks at two concrete data points from two separate 2026 industry reports, one from healthcare and one tied to financial services, to explain what these systems are actually doing, why the results vary so widely between organizations, and where the technology is headed next.

What Exactly Is an AI Agent

Before comparing industries, it helps to define the term, since it gets used loosely. An AI agent is a software system built to complete a goal with minimal supervision. It can:

  • Interpret a request or trigger event and break it into smaller steps
  • Pull information from multiple systems, such as an electronic health record, a payer portal, or a core banking platform
  • Make decisions within a defined scope, like approving a routine claim or flagging a suspicious transaction
  • Escalate to a human when it hits a case outside its authority or confidence level
  • Learn from outcomes to refine how it handles similar situations later

This is different from robotic process automation, which follows a fixed script, and different from a basic chatbot, which mostly retrieves and presents information. Agents are built to act, not just respond, which is why their impact tends to show up in operational metrics like staff hours saved or cost per transaction rather than in customer satisfaction scores alone.

It also helps to understand why 2026 specifically marks a turning point. For several years, agentic AI existed mostly as a research concept or a limited pilot confined to a single department. What changed this year is the maturity of the underlying infrastructure: large language models became reliable enough to handle multi-step reasoning without constant human correction, integration tools matured to the point where agents can operate inside existing software rather than requiring a full system overhaul, and enough early adopters had run these systems long enough to produce real performance data instead of vendor projections. That combination is why industry reports in 2026 are able to cite concrete percentages tied to staffing, cost, and return on investment rather than speculative estimates about future potential.

AI Agents in Healthcare: Cutting Administrative Burden

robot extending its hand

Healthcare has become one of the clearest proving grounds for agentic AI, largely because so much of the industry’s cost sits in administrative work rather than clinical care itself. According to a 2026 industry analysis from Ventus AI, healthcare organizations that have moved AI agents into full production are seeing reductions of 60 to 80 percent in the manual staffing needed for administrative functions, along with cost-per-claim improvements ranging from 40 to 55 percent. The report also points to organizations processing thousands of claim status checks daily through agents that operate directly inside existing payer portals, replacing work that would otherwise require several full-time coordinators.

This matters for a few reasons:

  • The gains are concentrated in back-office functions such as claim statusing, denial management, prior authorization, and eligibility verification, not in clinical decision-making
  • The agents described in this report do not require new API integrations with payer systems, which lowers the technical barrier for smaller health systems and dental service organizations to adopt them
  • Revenue cycle timelines are shrinking from months to days in some deployments, which has a direct effect on cash flow for providers

It is worth noting that these figures reflect organizations that have already reached full production, not early pilots. Plenty of healthcare systems are still testing agents in limited settings, and separate benchmarking work has found that adoption is outpacing measurement, meaning many organizations are deploying agents without a clear framework for verifying whether they are actually delivering value. The gap between “we deployed an agent” and “we can prove it works” is one of the more important undercurrents in healthcare AI adoption this year.

AI Agents in Finance: Driving Measurable ROI

Financial services tell a related but distinct story. A separate 2026 report from Second Talent found that banks and financial institutions are reporting a 77 percent return on investment from agent deployments, largely tied to risk checks, fraud detection, and operational tasks that previously required human review at every step. The same analysis notes that financial organizations are cutting operational costs by as much as 12 percent when agents take over compliance work and customer resolution tasks at scale.

A few patterns stand out in how finance is applying this technology:

  • Fraud detection and risk scoring benefit from agents that can process transactions continuously rather than in scheduled batches, catching anomalies faster
  • Compliance-related workflows, which are traditionally document-heavy and repetitive, are well suited to agents that can cross-reference regulations and flag exceptions
  • Customer resolution tasks, such as dispute handling, are being resolved without the delays that come from routing a case through several human reviewers

What separates the finance data point from the healthcare one is the type of value being measured. Healthcare’s 60 to 80 percent FTE reduction is a staffing and cost story. Finance’s 77 percent ROI figure is closer to a capital efficiency story, framed around what the institution gets back for every dollar invested in the technology. Both are meaningful, but they are not directly comparable metrics, and any leadership team looking at these numbers should be careful about assuming one industry’s results translate cleanly into another’s business case.

Comparing the Two Data Points: What the Numbers Reveal

Placing these two figures side by side is instructive. The healthcare figure is an operational efficiency measure rooted in labor reduction, while the finance figure is a financial return measure rooted in cost avoidance and risk mitigation. Both point to the same underlying trend: agents are most effective when applied to processes that are repetitive, rules-based, and high in volume, even if the specific process looks different from one sector to the next.

There is also a shared caveat behind both figures. In healthcare, the strongest results come from organizations with full production deployments and deep system integration, not from early pilots. In finance, ROI figures tend to be reported by institutions that have already worked through the harder governance and data-quality issues that trip up less mature deployments. In other words, both data points describe what is possible once an organization gets past the early, messy phase of adoption, not what every organization is currently experiencing. That distinction is easy to miss in headline statistics, but it is central to setting realistic expectations.

Beyond Healthcare and Finance: Other Industries Adopting AI Agents

Healthcare and finance are the two sectors with the most detailed 2026 data available, but they are far from the only ones investing in this technology. Retail, logistics, insurance, and manufacturing are all applying similar principles, adapted to their own bottlenecks.

  • Retail companies are using agents to manage inventory forecasting, dynamic pricing, and customer service, with some organizations reporting significant gross profit gains tied directly to agent-driven decisions
  • Insurance carriers are applying agents to claims processing and underwriting, with reported gains in staff efficiency, cost reduction, and customer service quality
  • Manufacturing operations are using agents to reduce downtime and material waste on factory floors, with meaningful annual savings tied to predictive maintenance
  • Logistics providers are using agents to handle shipment booking, route optimization, and exception handling when deliveries are delayed or rerouted

This broader spread across industries also touches the range of professions benefitting from groundbreaking tech, since the roles most affected are not limited to any single department. Claims adjusters, compliance officers, revenue cycle coordinators, customer service representatives, and supply chain planners are all seeing parts of their workload shift toward oversight of automated systems rather than manual execution of routine tasks. That shift changes the day-to-day nature of these jobs more than it eliminates them outright, at least based on current deployment patterns.

How AI Agents Actually Work Day to Day

It is worth walking through a concrete example to make the abstract description more tangible. Consider a healthcare organization using an agent for prior authorization, one of the most cited use cases in the space.

  • A request for a procedure comes in from a scheduling system
  • The agent checks the patient’s insurance details and the payer’s specific authorization rules
  • If the request meets standard criteria, the agent submits the authorization directly through the payer’s portal
  • If the case involves an unusual combination of procedure and diagnosis codes, the agent flags it for a human specialist rather than guessing
  • The agent logs the outcome and uses it to refine how it handles similar cases going forward

The same basic structure applies in finance, retail, or manufacturing, just with different triggers and different rules. A fraud detection agent watches transaction streams instead of scheduling systems. A retail agent watches inventory levels instead of insurance rules. The common thread is that the agent handles the routine 80 percent of cases and routes the harder 20 percent to a person, which is where most of the efficiency gains in both the healthcare and finance data points actually come from.

Challenges and Considerations for Adoption

Neither the healthcare nor the finance figures should be read as evidence that agent adoption is simple or guaranteed to succeed. Organizations considering this technology tend to run into a similar set of obstacles regardless of industry:

  • Integration depth matters more than most buyers expect; shallow integrations with existing systems tend to produce shallow results, while deeper integration with records, portals, or core systems tends to correlate with stronger returns
  • Governance and data quality are frequently cited as the deciding factor between deployments that reach positive returns and those that stall out before ever proving their value
  • Measurement discipline is often missing; many organizations can describe what an agent does but cannot yet say definitively how much time or money it has saved, which makes internal buy-in harder to sustain
  • Regulatory exposure is a live concern, particularly in healthcare and finance, where decisions made by an autonomous system can carry compliance or patient-safety consequences if left unchecked
  • Change management inside the workforce is frequently underestimated, since staff need new skills to supervise and correct agents rather than simply perform the tasks agents now handle

None of these challenges are unique to 2026, but they help explain why the reported results vary so widely between organizations in the same industry. The strongest numbers, like the ones cited above, tend to come from organizations that treated agent deployment as a structured operational change rather than a quick software rollout.

There is also a human dimension to adoption that rarely shows up in percentage figures but shapes how smoothly a rollout goes. Employees who spend their days on the tasks now handled by agents often need reassurance, training, and a clear sense of what their role becomes once the routine work is automated. Organizations that involve frontline staff early, asking them which parts of a workflow are genuinely repetitive and which require judgment, tend to design better guardrails for their agents than organizations that treat the rollout purely as an IT project. This is one reason the strongest results in both healthcare and finance tend to come from deployments where clinical, compliance, or operations staff were part of the design process rather than recipients of a finished system.

The Road Ahead for AI Agents

Looking at where things stand, a few trends seem likely to continue through the rest of 2026 and into 2027. Vertical, industry-specific agents built for healthcare billing, financial compliance, or insurance claims are outpacing general-purpose agents in measurable results, largely because they come pre-configured with the domain rules that would otherwise take months to build in-house. Multi-agent systems, where several specialized agents coordinate under a central process rather than one agent trying to do everything, are also gaining traction as organizations look for ways to handle more complex workflows without sacrificing accuracy.

At the same time, the gap between organizations that measure their agent deployments carefully and those that do not is likely to widen. The healthcare and finance figures discussed here represent what is achievable, not what is guaranteed, and the organizations most likely to reach similar results are the ones investing as much in integration, governance, and measurement as they are in the agents themselves.

Regulators are also expected to play a larger role in shaping how agents operate, particularly in sectors where an automated decision can directly affect a person’s health coverage or financial standing. Expect more formal auditing requirements, clearer disclosure rules around when a customer is interacting with an agent rather than a human, and industry-specific standards for what counts as an acceptable error rate. Rather than slowing adoption, these guardrails are likely to accelerate it among larger, more risk-conscious organizations, since clear rules tend to reduce the uncertainty that has kept some institutions on the sidelines. Smaller organizations without dedicated compliance teams may find this transition harder, which could widen the performance gap between large and small adopters even further over the next few years.

Final Thoughts

The 2026 data from healthcare and finance tells a consistent story even though the metrics differ. Agents are delivering real, measurable value where organizations apply them to high-volume, rules-based work and back that deployment with solid integration and governance. Healthcare’s administrative cost reductions and finance’s return on investment figures are two sides of the same underlying pattern: technology that handles routine decisions reliably enough to free people up for the exceptions that actually need human judgment. For any organization weighing whether to invest in this technology, the lesson from both sectors is the same. The results are real, but they belong to the organizations willing to do the harder integration and governance work first.